mNav Interactive Video + Navigator
BehavioralA personalized, video-based tool paired with navigator support to address individual screening barriers.
NCT Number: NCT07011836
The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African American women who are currently overdue for screening.
The main questions it aims to answer are:
Can an interactive video navigation tool (mNav), when paired with in-person navigation, improve screening adherence compared to a standard educational video alone?
Does the intervention improve knowledge, reduce barriers, and increase intentions to get screened?
Researchers will compare participants who receive both the interactive video (guided by an on-screen navigator) and in-person navigation to those who receive only a standard educational video to see if the tailored support increases screening rates.
Participants will:
Complete two phone surveys (one at the beginning and one six months later)
Be randomly assigned to one of two groups:
One group will receive an interactive video experience tailored to their concerns plus support from an in-person navigator
The other group will receive a standard educational video designed for African American women
Have their clinic records reviewed six months later to check for cervical cancer screening completion
Interested in participating?
Request Info21 year–65 year
Female
Interventional
Not applicable
Family and Medical Counseling Service, Inc., Washington D.C., District of Columbia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
*None
A personalized, video-based tool paired with navigator support to address individual screening barriers.
A culturally tailored cervical cancer education video without additional support or tailoring.
Time frame: Within 6 months of enrollment
Whether participants completed cervical cancer screening, as verified through medical record review. Screening includes a Pap test, HPV test, or co-test, consistent with current guidelines.
Time frame: Baseline and 6-month follow-up
Measures participants' self-reported likelihood of obtaining cervical cancer screening in the next 6 months. This is a single-item Likert scale ranging from 0 to 4, with higher scores indicating a greater likelihood of screening. Scale anchors are: 0 = Not at all likely, 1 = A little likely, 2 = Somewhat likely, 3 = Likely, 4 = Very likely.
Time frame: Baseline and 6-month follow-up
Assessed using a structured survey at baseline and follow-up, this 20-item True/False scale evaluates participant knowledge of cervical cancer risks, screening methods, and guidelines. Scale scores range from 0 to 20, with higher scores indicating greater knowledge. Each correct response is scored as 1; incorrect or missing responses are scored as 0. The total score represents the number of correct responses.
Contact information is provided by the study sponsor or research team.
ISA Associates, Inc.
Other
Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women
Acronym: mNav
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07702838
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hangzhou, Zhejiang, China
View Trial DetailsNCT04389632
Adenocarcinoma Of Esophagus, Adnexal Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT06400472
Adnexal Diseases, Breast Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT07646301
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Guangzhou, Guangdong, China
View Trial Details